Top of this page
Skip navigation, go straight to the content
Investor News
- Acquisition of own shares in the framework of employees’ long-term incentive plans 02-Feb-2012
- UCB and Astellas announce agreement to jointly develop and commercialize Cimzia® (certolizumab pegol) in Japan 01-Feb-2012
- Transparency Notification of Wellington management Company LLP 27-Jan-2012
- Acquisition of own shares in the framework of employees’ long-term incentive plans 26-Jan-2012
- UCB announces FDA approval for Keppra® in infants and children from one month of age with partial onset seizures 25-Jan-2012
- NYSE Euronext Brussels grants UCB the Best BEL 20 Performer Award 2011 23-Jan-2012
- Acquisition of own shares in the framework of employees’ long-term incentive plans 19-Jan-2012
